Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial

Autor: Ulrik Winsløw, Tharsika Sakthivel, Chaoqun Zheng, Helle Bosselmann, Ketil Haugan, Niels Bruun, Charlotte Larroudé, Kasper Iversen, Hillah Saffi, Emil Frandsen, Niels Risum, Henning Bundgaard, Christian Jøns

Publikováno v: Winsløw, U, Sakthivel, T, Zheng, C, Bosselmann, H, Haugan, K, Bruun, N, Larroudé, C, Iversen, K, Saffi, H, Frandsen, E, Risum, N, Bundgaard, H & Jøns, C 2022, ' Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST) : Study protocol for a randomized controlled trial ', American Heart Journal, vol. 253, pp. 59-66 . https://doi.org/10.1016/j.ahj.2022.07.003

Background: Low plasma potassium (p-K) is associated with increased risk of malignant arrhythmia and observational studies indicate protective effects of p-K in the upper reference level. However, randomized clinical studies are needed to document wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a9546a2095425cba08542a38cecfc9
https://pubmed.ncbi.nlm.nih.gov/35835265